Active, not recruitingNot applicableNCT05505227

Developing a Tailored Stigma Reduction Intervention to Increase Buprenorphine Prescribing

Studying Acute lymphoblastic leukemia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Ohio University
Principal Investigator
Berkeley Franz, Ph.D.
Ohio University Heritage College of Osteopathic Medicine
Intervention
Stigma-reduction training(behavioral)
Enrollment
400 enrolled
Eligibility
18 years · All sexes
Timeline
20222025

Study locations (1)

Collaborators

Ohio State University · Rutgers University · University of North Carolina

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05505227 on ClinicalTrials.gov

Other trials for Acute lymphoblastic leukemia

Additional recruiting or active studies for the same condition.

See all trials for Acute lymphoblastic leukemia

← Back to all trials